
Pfanstiehl Solutions for High-Concentration Antibody Formulations
By PfanstiehlThe development of high-concentration antibody formulations (HCAFs) of greater than 100mg/ml is essential for the creation of monoclonal antibody (mAb) therapies that can be delivered subcutaneously.
However, inevitable variability between molecules creates complex technical challenges that requires a broad set of tools and expertise to solve.
To read more, please download this free white paper.
